Volume 101, Issue 9

Search all Annals of Hematology articles

September 2022

35 articles in this issue

Hemolytic anemia in COVID-19
Hayder M. Al-kuraishy
Ali I. Al-Gareeb
Gaber El-Saber Batiha
Review Article 08 July 2022 Pages: 1887 - 1895
Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence
Sambhawana Bhandari
Maun Ranjan Baral
Oleg Sostin
Review Article 27 June 2022 Pages: 1897 - 1904
Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study
David Cella
Sujata P. Sarda
William R. Lenderking
Original Article Open access 23 July 2022 Pages: 1905 - 1914
Thrombopoietin receptor agonist discontinuation rates and reasons among patients with immune thrombocytopenia: a study of administrative claims linked with medical chart review
Adam Cuker
Lincy Lal
Ricardo Viana
Original Article 18 July 2022 Pages: 1915 - 1924
Adult Langerhans cell histiocytosis with thyroid gland involvement: clinical presentation, genomic analysis, and outcome
Hua-cong Cai
Ting Liu
Xin-xin Cao
Original Article 02 July 2022 Pages: 1925 - 1929
Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis
Nadirah El-Amin
Audra Iness
Oliver Karam
Original Article 27 July 2022 Pages: 1931 - 1940
Frequency, pattern, and associations of renal iron accumulation in sickle/β-thalassemia patients
Antonella Meloni
Luigi Barbuto
Filippo Cademartiri
Original Article 11 July 2022 Pages: 1941 - 1950
Phenotypes of sickle cell intensive care admissions: an unsupervised machine learning approach in a single-center retrospective cohort
Eduardo Messias Hirano Padrão
Brian Bustos
Leandro Utino Taniguchi
Original Article 15 July 2022 Pages: 1951 - 1957
An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19
Hideaki Matsuura
Sumie Fujii
Yasuo Miura
Original Article 14 July 2022 Pages: 1959 - 1969
Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria
Raymond S. M. Wong
Humphrey W. H. Pullon
Federico V. Grossi
Original Article Open access 22 July 2022 Pages: 1971 - 1986
Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing
Madhavi Maddali
Arvind Venkatraman
Poonkuzhali Balasubramanian
Original Article 15 July 2022 Pages: 1987 - 2000
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis
Shai Shimony
Jonathan Canaani
Ofir wolach
Original Article 24 June 2022 Pages: 2001 - 2010
Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis
Shai Shimony
Jonathan Canaani
Ofir wolach
Correction 23 July 2022 Pages: 2011 - 2011
Low cerebrospinal fluid-to-plasma ratios of orally administered lenalidomide mediated by its low cell membrane permeability in patients with hematologic malignancies
Daisuke Ogiya
Norie Murayama
Hiroshi Yamazaki
Original Article 22 June 2022 Pages: 2013 - 2019
Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma
Fei Qi
Yan Xie
Jun Zhu
Original Article 08 July 2022 Pages: 2021 - 2034
A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children’s Cancer Group
Yi-Jin Gao
Yong-Jun Fang
Jing-Yan Tang
Original Article 13 July 2022 Pages: 2035 - 2043
Lowering platelet count threshold to 10,000/µL for peripherally inserted central catheter placement safely conserves blood products
Roxana Amirahmadi
Scott Sullivan
Michael T. McCurdy
Original Article 28 June 2022 Pages: 2045 - 2052
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients
José Luis Piñana
Pablo Rodríguez-Belenguer
On behalf of Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)
Original Article 02 July 2022 Pages: 2053 - 2067
Peripherally inserted central venous catheters decrease central line-associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score-adjusted analysis
Yosuke Nakaya
Mika Imasaki
Takahisa Yamane
Original Article 02 July 2022 Pages: 2069 - 2077
Correction to: Peripherally inserted central venous catheters decrease central line‑associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score‑adjusted analysis
Yosuke Nakaya
Mika Imasaki
Takahisa Yamane
Correction 12 July 2022 Pages: 2079 - 2079
Hepatitis B reactivation during ruxolitinib treatment
Marissa Sjoblom
Haithem Chtioui
Sabine Blum
Letter to the Editor 30 April 2022 Pages: 2081 - 2086
Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis
Valentino Dammassa
Alessandra Greco
Guido Tavazzi
Letter to the Editor 11 May 2022 Pages: 2087 - 2088
SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness
Malte B. Monin
Benjamin Marx
Annkristin Heine
Letter to the Editor Open access 24 May 2022 Pages: 2089 - 2090
Neuroimaging of leptomeningeal myelomatosis: a rare and severe entity
Teresa Perillo
Carmela Somma
Andrea Manto
Letter to the Editor 07 May 2022 Pages: 2091 - 2092
Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia
Benjamin Podvin
Hélène Guermouche
Catherine Roche-Lestienne
Letter to the Editor 13 May 2022 Pages: 2093 - 2095
Increased blood levels of venetoclax due to intake of crushed venetoclax tablets
Maiko Anzai
Takeo Yasu
Masayuki Kobayashi
Letter to the Editor 26 May 2022 Pages: 2097 - 2098
Successful treatment of Kimura disease with benralizumab
Vivian G. Szeto
Benjamin Chin-Yee
Cyrus C. Hsia
Letter to the Editor 27 May 2022 Pages: 2099 - 2100
The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia
Xinhong Yang
Rongjuan Zhang
Zhihua Zhang
Letter to the Editor 15 June 2022 Pages: 2101 - 2102
Severe platelet transfusion refractoriness due to anti-HPA-5a antibody during induction chemotherapy for acute promyelocytic leukemia
Kei Saito
Satoshi Ichikawa
Tohru Izumi
Letter to the Editor 25 May 2022 Pages: 2103 - 2105
Understanding the EKG changes in methemoglobinemia
Pramukh Arun Kumar
Mahati Dasari
Ajay K. Mishra
Letter to the Editor 20 June 2022 Pages: 2107 - 2110
Rhabdomyolysis induced by nelarabine
Christian Späth
Mandy Schönau
William H. Krüger
Letter to the Editor Open access 17 June 2022 Pages: 2111 - 2112
A novel compound heterozygous mutation of von Hippel-Lindau gene in a Chinese patient with erythrocytosis
Jun-Nan Li
Xiao-Hua Luo
Ping Li
Letter to the Editor 29 June 2022 Pages: 2113 - 2114
Correction to: A novel compound heterozygous mutation of von Hippel‑Lindau gene in a Chinese patient with erythrocytosis
Jun‑Nan Li
Xiao‑Hua Luo
Ping Li
Correction 13 July 2022 Pages: 2115 - 2115
Serum levels of albumin and creatinine predict the outcome of sinusoidal obstruction syndrome after allogeneic HSCT
Souichi Shiratori
Kohei Okada
Takanori Teshima
Letter to the Editor 20 June 2022 Pages: 2117 - 2118
Belantamab mafodotin in patients with relapsed/refractory AL amyloidosis with myeloma
Yifei Zhang
Amandeep Godara
Ankit Kansagra
Letter to the Editor 12 July 2022 Pages: 2119 - 2121

Volume 101, Issue 9

Hemolytic anemia in COVID-19

Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence

Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study

Thrombopoietin receptor agonist discontinuation rates and reasons among patients with immune thrombocytopenia: a study of administrative claims linked with medical chart review

Adult Langerhans cell histiocytosis with thyroid gland involvement: clinical presentation, genomic analysis, and outcome

Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis

Frequency, pattern, and associations of renal iron accumulation in sickle/β-thalassemia patients

Phenotypes of sickle cell intensive care admissions: an unsupervised machine learning approach in a single-center retrospective cohort

An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19

Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria

Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing

Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis

Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis

Low cerebrospinal fluid-to-plasma ratios of orally administered lenalidomide mediated by its low cell membrane permeability in patients with hematologic malignancies

Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma

A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children’s Cancer Group

Lowering platelet count threshold to 10,000/µL for peripherally inserted central catheter placement safely conserves blood products

Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients

Peripherally inserted central venous catheters decrease central line-associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score-adjusted analysis

Correction to: Peripherally inserted central venous catheters decrease central line‑associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score‑adjusted analysis

Hepatitis B reactivation during ruxolitinib treatment

Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis

SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness

Neuroimaging of leptomeningeal myelomatosis: a rare and severe entity

Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia

Increased blood levels of venetoclax due to intake of crushed venetoclax tablets

Successful treatment of Kimura disease with benralizumab

The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia

Severe platelet transfusion refractoriness due to anti-HPA-5a antibody during induction chemotherapy for acute promyelocytic leukemia

Understanding the EKG changes in methemoglobinemia

Rhabdomyolysis induced by nelarabine

A novel compound heterozygous mutation of von Hippel-Lindau gene in a Chinese patient with erythrocytosis

Correction to: A novel compound heterozygous mutation of von Hippel‑Lindau gene in a Chinese patient with erythrocytosis

Serum levels of albumin and creatinine predict the outcome of sinusoidal obstruction syndrome after allogeneic HSCT

Belantamab mafodotin in patients with relapsed/refractory AL amyloidosis with myeloma

Navigation